Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2019-04-11 Capital/Financing Update
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos creates new warrant plans
Capital/Financing Update Classification · 98% confidence The document announces the creation of 2,070,000 new warrants under new warrant plans for employees, directors, and a consultant. This action directly relates to changes in the company's capital structure, specifically the issuance of rights to acquire new shares. This falls under the definition of Capital/Financing Update (CAP). Although it involves shares, it is about the creation of options/warrants rather than a direct share issue/repurchase (SHA/POS), and it is a financing/incentive mechanism. The document is a formal announcement (gereglementeerde informatie) detailing the terms of these new capital instruments.
2019-04-11 Dutch
Galapagos creates new warrant plans
Capital/Financing Update Classification · 98% confidence The document explicitly announces that the board of directors created 2,070,000 warrants under new warrant plans for employees, directors, and a consultant. It details the exercise price, term, and the impact on the total number of voting rights and potential shares. This action directly relates to changes in the company's capital structure and financing instruments (warrants). Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a general earnings release (ER), a full annual report (10-K), or a simple announcement of a report (RPA).
2019-04-11 English
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Galapagos NV, for the month of April 2019. It references a press release attached as Exhibit 99.1 dated April 10, 2019. The document is only 2593 characters long and primarily serves as a regulatory filing to provide information and incorporate by reference a press release. There is no substantive financial data, detailed report, or financial statements included. According to the rules, such filings that are primarily regulatory announcements or references to other documents without detailed financial content should be classified as Regulatory Filings (RNS).
2019-04-11 English
Warrant Plan 2019 - 2019 RMV_ENG.pdf
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the creation of new warrant plans for employees, directors, and consultants, detailing the number of warrants (2,070,000), the exercise price, and the terms. This action directly relates to changes in the company's capital structure and financing instruments (warrants granting the right to subscribe to new shares). This fits the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a general regulatory filing (RNS), as it concerns a specific corporate financing action.
2019-04-10 English
Warrant Plan 2019 - 2019 RMV_NL.pdf
Share Issue/Capital Change Classification · 99% confidence The document announces the creation of new warrant plans (Warrantplan 2019 RMV and Warrantplan 2019) by the Board of Directors, involving the creation of 2,070,000 warrants for employees and directors. This action directly relates to changes in the company's capital structure and financing instruments (warrants are rights to subscribe to new shares). This fits the definition of 'Capital/Financing Update' (CAP). It is not an earnings release, an annual report, or a simple dividend announcement. Since it details the creation and terms of new securities intended to raise capital or incentivize employees via equity, CAP is the most appropriate classification.
2019-04-10 Dutch
EN report Deloitte_10 April 2019.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled as a "Statutory auditor's report to the board of directors" concerning the "Issuance of shares with cancellation of the preferential subscription right" under specific articles of the Belgian Companies Code (596 and 598). It reviews a special report from the board of directors and provides an opinion on the sufficiency of financial information for shareholders regarding a warrant plan. This document is a formal, standalone report related to accounting/audit verification concerning a corporate action (share issuance/cancellation of rights), which aligns best with the definition of an Audit Report / Information (AR), as it is not the full Annual Report (10-K) or a general Earnings Release (ER). It is a specific audit verification report.
2019-04-10 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.